These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 16007095)

  • 21. Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells.
    Chung SS; Kim M; Youn BS; Lee NS; Park JW; Lee IK; Lee YS; Kim JB; Cho YM; Lee HK; Park KS
    Mol Cell Biol; 2009 Jan; 29(1):20-30. PubMed ID: 18936159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra.
    Whitehead JP
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1071-4. PubMed ID: 21558015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ENaC- and CFTR-dependent ion and fluid transport in human middle ear epithelial cells.
    Choi JY; Son EJ; Kim JL; Lee JH; Park HY; Kim SH; Song MH; Yoon JH
    Hear Res; 2006 Jan; 211(1-2):26-32. PubMed ID: 16226002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional gene targeting of the ENaC subunit genes Scnn1b and Scnn1g.
    Mérillat AM; Charles RP; Porret A; Maillard M; Rossier B; Beermann F; Hummler E
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F249-56. PubMed ID: 19036848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of Na+ transport and epithelial sodium channel expression by protein kinase C in rat alveolar epithelial cells.
    Yamagata T; Yamagata Y; Massé C; Tessier MC; Brochiero E; Dagenais A; Berthiaume Y
    Can J Physiol Pharmacol; 2005 Nov; 83(11):977-87. PubMed ID: 16391706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
    Yoshioka K; Wakino S; Homma K; Kanda T; Tatematsu S; Hasegawa K; Sugano N; Ito O; Omata K; Saruta T; Hayashi K
    Obesity (Silver Spring); 2008 May; 16(5):965-71. PubMed ID: 18277387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can PPARgamma agonists have a role in the management of obesity-related hypertension?
    Chetty VT; Sharma AM
    Vascul Pharmacol; 2006 Jul; 45(1):46-53. PubMed ID: 16713364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary abscisic acid ameliorates glucose tolerance and obesity-related inflammation in db/db mice fed high-fat diets.
    Guri AJ; Hontecillas R; Si H; Liu D; Bassaganya-Riera J
    Clin Nutr; 2007 Feb; 26(1):107-16. PubMed ID: 17000034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney-specific gene targeting: insight into thiazolidinedione-induced fluid retention.
    Yang T
    Nephrology (Carlton); 2006 Jun; 11(3):201-6. PubMed ID: 16756632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
    Renauld S; Tremblay K; Ait-Benichou S; Simoneau-Roy M; Garneau H; Staub O; Chraïbi A
    J Membr Biol; 2010 Aug; 236(3):259-70. PubMed ID: 20740360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.
    Karalliedde J; Buckingham RE
    Drug Saf; 2007; 30(9):741-53. PubMed ID: 17722967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabonomic profiling revealed an alteration in purine nucleotide metabolism associated with cardiac hypertrophy in rats treated with thiazolidinediones.
    Liu Y; Yan X; Mao G; Fang L; Zhao B; Liu Y; Tang H; Wang N
    J Proteome Res; 2013 Dec; 12(12):5634-41. PubMed ID: 24164426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute regulation of the epithelial sodium channel gene by vasopressin and hyperosmolality.
    Machida K; Nonoguchi H; Wakamatsu S; Inoue H; Yosifovska T; Inoue T; Tomita K
    Hypertens Res; 2003 Aug; 26(8):629-34. PubMed ID: 14567502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lose salt and gain a friend! A tribute to Gerhard Giebisch.
    Rossier BC
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):504-6. PubMed ID: 9261995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity.
    Vallon V; Hummler E; Rieg T; Pochynyuk O; Bugaj V; Schroth J; Dechenes G; Rossier B; Cunard R; Stockand J
    J Am Soc Nephrol; 2009 Apr; 20(4):721-9. PubMed ID: 19158355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors.
    Pavlov TS; Imig JD; Staruschenko A
    PPAR Res; 2010; 2010():703735. PubMed ID: 20613963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased susceptibility of db/db mice to rosiglitazone-induced plasma volume expansion: role of dysregulation of renal water transporters.
    Zhou L; Liu G; Jia Z; Yang KT; Sun Y; Kakizoe Y; Liu M; Zhou S; Chen R; Yang B; Yang T
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1491-7. PubMed ID: 24005472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?
    Goltsman I; Khoury EE; Winaver J; Abassi Z
    Pharmacol Ther; 2016 Dec; 168():75-97. PubMed ID: 27598860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
    Rusinova R; Herold KF; Sanford RL; Greathouse DV; Hemmings HC; Andersen OS
    J Gen Physiol; 2011 Aug; 138(2):249-70. PubMed ID: 21788612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.